Evidence map›Paper›PMID 33170427›Full record

ArticleMolecular biology reports2020

Orexin-A up-regulates dopamine D2 receptor and mRNA in the nucleus accumbens Shell.

Sandra Morales-Mulia, Víctor Manuel Magdaleno-Madrigal, Humberto Nicolini, Alma Genis-Mendoza, Marcela Morales-Mulia

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Sandra Morales-MuliaDepartamento de Biología Celular, Facultad de Ciencias, UNAM, Mexico, DF, Mexico.ORCID http://orcid.org/0000-0002-9100-9208
Víctor Manuel Magdaleno-MadrigalNeurofisiología del Control y la Regulación, Dirección de Neurociencias, INPRFM, Mexico, DF, Mexico.ORCID http://orcid.org/0000-0002-5354-2204
Humberto NicoliniLaboratory of Genomics of Psychiatric Diseases, Neurodegenerative and Addictions, National Institute of Genomic Medicine, Mexico, Mexico.ORCID http://orcid.org/0000-0003-2494-0067
Alma Genis-MendozaLaboratory of Genomics of Psychiatric Diseases, Neurodegenerative and Addictions, National Institute of Genomic Medicine, Mexico, Mexico.ORCID http://orcid.org/0000-0001-8180-477X
Marcela Morales-MuliaBases Moleculares de las Adicciones, Subdirección de Investigaciones Clínicas, INPRFM, Calzada México-Xochimilco 101, San Lorenzo Huipulco, Tlalpan, 14370, Mexico, DF, Mexico. mmulia@imp.edu.mx.ORCID http://orcid.org/0000-0002-5549-0866
Hospital Psiquiatrico Infantil Juan N Navarro · MXInstituto Nacional de Investigaciones Nucleares · MXInstituto Nacional de Neurología y Neurocirugía · MXNational Institute of Genomic Medicine · MXUniversidad Nacional Autónoma de México · MX

Funding

Consejo Nacional de Ciencia y Tecnología 241216Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz IC16033.0
6 · The paper itself

Abstract

Orexins-A (OrxA) and -B (OrxB) neuropeptides are synthesized by a group of neurons located in the lateral hypothalamus and adjacent perifornical area, which send their projections to the mesolimbic dopaminergic (DAergic) system including ventral tegmental area and nucleus accumbens (NAc), where orexin receptors are expressed. NAc plays a central role in reward-seeking behavior and drug abuse. NAc-neurons express dopamine-1 (D1R) and dopamine-2 (D2R) receptors. Orexins bind to their two cognate G-protein-coupled receptors, orexin-receptor type-1 (Orx

Indexed as

AnimalsDopaminergic NeuronsGene Expression RegulationInjections, IntraventricularMaleNucleus AccumbensOrexinsProtein BindingRatsRats, WistarReceptors, Dopamine D1Receptors, Dopamine D2RNA, MessengerSignal TransductionStereotaxic TechniquesOrexinsReceptors, Dopamine D1Receptors, Dopamine D2RNA, MessengerDopamine receptorsMesolimbic systemNucleus accumbensOrexin system

Identifiers

PMID33170427
OpenAlexW3103007024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.